ABSTRACT
INTRODUCTION
Urinary tract infections (UTIs) are considered to be the second most frequent bacterial infection among human and is widely responsible for nosocomial infections in both developed and undeveloped countries. 1 The studies showed that about 5% of men and 40-50% of women develop UTI in their lifetime and it accounts for more than 100,000 hospitalizations and spends about 1.6 billion dollars in medical expenses each year. 2 UTI is caused by a variety of pathogens and uropathogenic Escherichia coli which accounts for approximately 75% of the isolates and being the most common etiological agent followed by Klebsiella pneumonia. 3 However,
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Antimicrobial activity of Prunella Vulgaris extracts against multi-drug resistant Escherichia Coli from patients of urinary tract infection emergence of resistance to commonly used antibiotics in UTI has become a great challenge. Multidrug resistance is defined as an antimicrobial resistance shown by certain microorganisms to a number of antimicrobial drugs. Antimicrobial resistance is related to high rate of morbidity, mortality, increased treatment cost, hospital stay and decreased effectiveness of antimicrobial agents. 4 Mostly herbal medicines are used in the development of new medicines and bring significant economic support in the treatment of many diseases. 5 Prunella vulgaris (PV), a perennial plant widely distributed in Europe and East Asia, is commonly known as "self-heal" due to its quick wound healing effects. 6 Keeping in view the properties of PV, the objective of present study are there for to investigate the antimicrobial activity of aqueous and ethanolic extracts of Prunella vulgaris against E. coli from urinary tract infection patients. 
METHODS

Samples
Plant Extract Preparation:
Prunella vulgaris Aqueous Extract: Dried Prunella vulgaris aqueous extraction were prepared by grinding it followed by soaking in water (1 L) for 2 hour and then boiled in distilled water for 2 hr at 100°C. The extract was cooled at room temperature and supernatant was then filtered through Whatman No.1 filter paper. Residues were reconstituted with distilled water and were used in the study followed by freeze drying.
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Prunella vulgaris Ethanolic Extract: Plant dried material was grinded and extracted with 95% ethanol by using Soxhlet extractors, the extract was concentrated by rotary evaporation at less than 30°C and was lyophilized. 
Minimum Inhibitory Concentration of Plant Extracts:
The minimum inhibitory concentration (MIC) of Quinolones, Cephalosporins and plant extracts were analyzed by using broth microdilution method. 9 According to the Clinical Laboratory Standards Institute, guidelines 2011, serial dilutions of plant materials with significant antimicrobial activity with 5 × 105 (CFU) /mL were prepared. 10 Ethanolic extract were diluted two folds to develop a series of concentrations by using brain heart infusion (BHI) broth. MIC was evaluated at lowest conc. of PV extract i.e. 0.125 μg/μL without any visible bacterial growth in wells of 96 well plates. Statistical Analysis: Statistical analysis was done by using SPSS 16.0, t-test and one way ANOVA was used to determine the significance difference among all the experimental groups (p≤0.05).
RESULTS
Out of 44 Samples, 38 (86.4%) urine samples carried E. coli with high rates of MDR E. coli (82%), (Table-I ). The zone of inhibition against resistant strains of E. coli was measured, tobramycin at concentration 10(μg) had a zone of inhibition 16.16(±0.822) mm as compared to ciprofloxacin, ofloxacin, cefixime with zone of inhibition at concentration of 5μg, 10.79 (±1.329), 10.02(±1.107) and 7.37(±0.54) respectively. Therefore tobramycin at 10 microgram inhibited the resistant E. coli to a greater extent as compared to other antibiotics ( Table-II) . The mean MIC of ciprofloxacin, ciprofloxacin plus aqueous extract of Prunella vulgaris, ciprofloxacin with ethanolic extract of Prunella vulgris and Ciprofloxacin with both aqueous and ethanolic extract of Prunella vulgris is 0.5 ± 0.00 µgm/µl, 2 ± 0.00µgm/µl, 1.33 ± 0.33µgm/µl, 1.83 ± 1.09 µgm/ µl, 2.16 ± 1.0179µgm/µl and 1.33 ± 0.33µgm/µl respectively. Therefore Ciproflaxacin alone has greater zone of inhibition on lesser dose 0.5 μg/ μL as compared to Prunella vulgaris extracts (both aqueous and ethanolic) and in combination with Ciprofloxacin. Therefore it is suggested that Prunella vulgaris has no synergistic effect with Ciproflxacin. (Table-III) .
The mean MIC of Cefixime, aqueous extract of Prunella vulgris, ethanolic extract of Prunella vulgaris, Cefixime plus aqueous extract of Prunella vulgaris, Cefixime with ethanolic extract of Prunella vulgaris and Cefixime with both aqueous and ethanolic extract of Prunella vulgris 8.83 ± 0.00 µgm/µl, 2 ± 0.00 µgm/µl, 2 ± 0.00 µgm/µl, 1.33 ± 0.33 µgm/µl, 1.5 ± 0.50µgm/µl and 4.0 ± 0.00 µgm/ µl respectively. Therefore Cefiximewith aqueous extract of Prunella vulgaris has greater zone of inhibition on lesser dose as compared to Prunella vulgaris extracts (both aqueous and ethanolic) andCefixime alone. Therefore it is suggested that Cefixime plus aqueous extract of Prunella vulgaris has synergistic effect with cefixime (see Table-IV) .
DISCUSSION
Antibiotics resistance to urinary tract pathogens has been raising globally from many years. Multi-drug resistant bacteria are serious threat in clinical health settings and very challenging to treat infectious disease. 12 From current study it was found that 82% of clinical isolates of Escherichia coli have multi drug resistance pattern. Increased rate of prevalence in the present study indicate the irrational use of antibiotics in clinical practice. Approximately 80% of antimicrobial administration is unnecessary. This misuse of antimicrobials plays a significant role in the development of resistance among microorganisms and produce considerable adverse effects on human health. 13 High prevalence rates of antibiotic-resistant strains of Escherichia coli complicate the management of urinary tract infections. 14 In the present study antibiotic sensitivity testing was done by using four antibiotics include Ciprofloxacin, Ofloxacin, Cefixime and Tobramycin and found that Tobramycin (10μg) have higher zone of inhibition as compared to Fluoroquinolones and Cephalosporins which are commonly used for the treatment of urinary tract infection or a number of other bacterial infections. 15 From previous studies it was found that Fluoroquinolones have lost their activity against MDR gram negative bacteria and it is very difficult to restore it, however, the use of tobramycin as an adjuvant can help to improve Fluoroquinolones activity. 16 The irrational use of these medicines is the leading cause of development of resistance.
Resistance to antimicrobial is more threatening because only a limited number of new antimicrobial agents have been developed. 17 Natural herbs have been used in treating a variety of illness and play a major role in the preparation of modern medicine. 18, 19 In the current study an attempt is made to find out the activity of Prunella vulgaris against MDR strains of E. coli. From previous studies it has been revealed that PV can inhibit the bacterial growth. In this study ethanolic and aqueous extract of P. vulgaris was prepared the average MIC of aqueous extract was 2μg/μl which is more than the MIC of ethanolic extract of P. vulgaris that was 1 μg/μl. Antibacterial combination most commonly used by the practitioners to treat bacterial infection as the synergistic effect of two or more medicine improve the overall effect of conventional antibiotics by increasing its efficacy, reducing toxicity and provide broad spectrum activity against microbes. 19 Resistance behaviors of MDR E. coli were modified by using P. vulgaris plant extract in combination with conventional medicine. From the current study, it was found that P. vulgaris along with conventional antibiotics against UTI have shown better results by exhibiting average MIC of 0.5μg/μl.
CONCLUSION
Aqueous and ethanolic extract alone and in combination have positive effect against multi-drug resistant E. coli strain isolated from patients with urinary tract infection. In this study it is suggested that; 1. E. coli is positive to 86.4% of urine samples.
Focus on MDR E. coli. 2. Tobramycin has greater efficacy against resistant E. coli as compared to other antibiotics. 3. Ciprofloxacin has more efficacy than aqueous or ethanolic extract of PV. 4. Ciprofloxacin has no synergistic effect with PV extracts. 5. Cefixime is least efficacious against resistant E. coli however it has synergistic effect with extracts of PV. Hence, it is concluded that P vulgaris can be used as supportive therapy along with the standard antibiotics used to treat UTI.
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